Skip to content

Clinical trials

Memory Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Memory Disorders Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20111
20121
20131
20151
20175
20183
20201
20223
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting5
Active, not recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre for Addiction and Mental Health2
University of Manitoba2
AZTherapies, Inc.1
AbbVie1
Acumen Pharmaceuticals1
Aker BioMarine Human Ingredients AS1
BC Mental Health and Addictions Research Institute1
CHU de Quebec-Universite Laval1
Douglas Mental Health University Institute1
Eisai Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Memory Disorders24
Cognitive Dysfunction10
Alzheimer Disease8
Dementia5
Pick Disease of the Brain2
Psychotic Disorders2
Schizophrenia2
Tauopathies2
Cognition Disorders1
Confusion1

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.